Publication | Open Access

Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer

Metastatic Breast CancerOncologyBreast OncologyMedicineCancer ManagementBreast CancerPharmacotherapyCancer TreatmentPharmacologyEpirubicin Dose IntensityFec Regimen